| Term 
 
        | Female Sex Steroid Hormones |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pituitary Gonadotropin Hormones |  | Definition 
 
        | Follicle Stimulating Hormone (FSH)   Luteinizing Hormone (LH) |  | 
        |  | 
        
        | Term 
 
        | Classifications of Oral Contraceptions |  | Definition 
 
        | 1) combo: estrogen and progestin   2) Progestin only |  | 
        |  | 
        
        | Term 
 
        | Categories of combo Oral contraceptives |  | Definition 
 
        | 1) Monophasic   2) Biphasic-rare   3) triphasic-most like women's hormones |  | 
        |  | 
        
        | Term 
 
        | Uses for Contraceptive Drugs |  | Definition 
 
        | 1) prevent pregnancy   2) treat endometriosis and hypermenorrhea   3) produce cyclic withdrawal bleeding   4) postcoital emergency contraception |  | 
        |  | 
        
        | Term 
 
        | Contraindications of combo OC's |  | Definition 
 
        | Absolute: thrombophlebitis, CVA, abnormal liver, smokers over 35, suspected pregnancy, breast cancer,   Relative: HTN, cardiac disease, diabetes, gallbladder disease, epilepsy, migraines, uterine leiomyoma |  | 
        |  | 
        
        | Term 
 
        | NonContraceptive Benefits of OC |  | Definition 
 
        | decrease risk of ovarian and endometrial cancer, PID, benign breast disease, anemia, acne   reduce cramps, lighter,shorter, and more predictable flow |  | 
        |  | 
        
        | Term 
 
        | Adverse Effects of combo OC's |  | Definition 
 
        | thromboembolic disorders HTN, Cancer teratogenic effect uterine bleeding benign hepatic adenoma glucose intolerance edema, dizziness, headache, depression, n/v, weight gain |  | 
        |  | 
        
        | Term 
 
        | Combo OC Drug interactions that reduce the effects of OC's |  | Definition 
 
        | Anti-TB antivirals antiepileptic drugs st. john's wart barbituates antibiotics |  | 
        |  | 
        
        | Term 
 
        | Comb OC drug interactions whose effects are reduced by OC's |  | Definition 
 
        | warfarin insulin hypoglycemias beta blockers |  | 
        |  | 
        
        | Term 
 
        | Combo OC drug interactions whose effects are increased by OC's |  | Definition 
 
        | theophyline-bronchodilator imipramine-antidepressant |  | 
        |  | 
        
        | Term 
 
        | Long Acting Contraceptives |  | Definition 
 
        | Subdermal etonorgestrel implant depot medroxprogesterone acetate "depo shot' intrauterine devices |  | 
        |  | 
        
        | Term 
 
        | Shorter acting contraceptives |  | Definition 
 
        | Spermicides Barrier devices -condomes -diaphragm -cervical cap |  | 
        |  | 
        
        | Term 
 
        | Mifepristone with Misoprostol |  | Definition 
 
        |   blocks uterine progestone receptors then cervix softens and induction of labor   |  | 
        |  | 
        
        | Term 
 
        | Methotrexate with misprostol |  | Definition 
 
        | interfers with growth of placenta and detaches from lining and softens cervix and induces labor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Misoprostol, carboprost, dinoprostone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Emergerncy contraceptive 2 high dose progestin 1 w/i 72 hours another 12 hours later |  | 
        |  | 
        
        | Term 
 
        | Major Endogenous Estrogens |  | Definition 
 
        | 1) estradiol- most active   2) estrone   2) estriol |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1) steroidal -conjugated estrogens, estradio, transdermal   2) nonsteroidal- not available in US -chlorotrianisene |  | 
        |  | 
        
        | Term 
 
        | Estrogen is required for: |  | Definition 
 
        | 1) develop and maintenance of female reproduction   2) secondary sex characteristics |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1) treat/prevent estrogen deficiency -atrophic vaginitis  -dysmenorrhea -hot flashes  -uterine bleeding -osteopororsis   2) Continuous combined hormone replacement therapy -fixed estrogen/progestin combo products  |  | 
        |  | 
        
        | Term 
 
        | Estrogen Contraindications |  | Definition 
 
        | Estrogen dependent cancer   abnormal vaginal bleeding   prognancy   thromboembolic disorder/history |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | N/V/D/C abdominal pain HTN, edema thrombolytic events phtosensitvity/chloasma amenorrhea, break through bleeding fluid retention, tender breasts, HA |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Synthetic 1) Provera 2) Megace 3) hydroxyprogesterone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dysfunctional uterine bleeding from hormones, fibroids, cancer   primary/secondary amenorrhea   prevent miscarriage   alleviate PMS   management of anorexia/aids and cancer pnts b/c increase appetite |  | 
        |  | 
        
        | Term 
 
        | Progestins Adverse Effects   |  | Definition 
 
        | Liver dysfunction   thrombophlebitis   N/V/edema/weight gain amenorrhea/bleeding/spotting |  | 
        |  | 
        
        | Term 
 
        | Estrogen and Progestin Nursing Implications |  | Definition 
 
        | Photosensitivity   report weight gain of 10lb in 3 months   follow up with papsmear and breast exam   small dose needed   what to do if miss dose   take PO w/ meal, IM deep and rotate |  | 
        |  | 
        
        | Term 
 
        | Bisphosphonates and Calcitonin |  | Definition 
 
        | -Fasomax (B) Calcitonin (H)   prevention and treatment   biphosphanates used for glucocorticoid induced osteoporosis and Paget's disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Evista (SERM)   prevent of postmenopausal osteoporosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Forteo (hormone)   used for those with highest risk of fractures- grows bone back |  | 
        |  | 
        
        | Term 
 
        | Adverse Effects of Bisphosphonates |  | Definition 
 
        | HA, GI upset, Joint pain Risk of esophageal burns- need to sit up 30mins |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Same symptoms of Menopause -hot flashes  -leg cramps -risk venous thromboembolism -leukopenia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SERMS- d/c 72 hours before and during any prolonged immobility   monitor for therapeutic effect ex DXA scan Monitor for adverse effects |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nonsteroidal ovulation stimulant blocks estrogen receptors in the uterus and brain- false low estrogen causes increase Gn-Rh, FSH, and LH causes maturation of ovarian follicles causes ovulation and increases conception |  | 
        |  | 
        
        | Term 
 
        | Clomiphene (Clomid) Adverse Effects |  | Definition 
 
        | enlarged ovaries hot flashes, mood swings abdominal/pelvic pain N/V, HA breast pain, abnormal bleeding increased appetite |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mixture of FSH and LH stimulates development of ovarian follicles causes ovulation can be given to men for spermatogenesis |  | 
        |  | 
        
        | Term 
 
        | chorionic gonadotropin alfa (Ovidrel) |  | Definition 
 
        | recombinant form of HCG -cause rupture and ovulation of mature ovarian follicle and maintenance of corpus luteum used to stimulate ovulation |  | 
        |  | 
        
        | Term 
 
        | Fertility Drug Indication |  | Definition 
 
        | induce ovulation in anovulatory patients   promote spermatogensis in infertile men |  | 
        |  | 
        
        | Term 
 
        | Fertility Drugs Adverse Effects |  | Definition 
 
        | tachycardia, phlebitis, DVT dizzy, HA, flush, depression, anxiety, nervous, fatigue N/bloat/constipation Ovarian hyperstimulation multi preggers blurred vision, breast pain |  | 
        |  | 
        
        | Term 
 
        | Fertility Drug Nursing IMplication |  | Definition 
 
        | take drugs as ordered-essential for effective outcomes   keep journal while on drugs   emotional support |  | 
        |  | 
        
        | Term 
 
        | Uterine Active Medications |  | Definition 
 
        | Alter uterine contractions   promote labor   prevent start/progression of labor   decrease risk of postpartum hemorrhage |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increase force and frequence of contractions prevent postpartum uterine atony and hemorrhage |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | natural hormone potent contractions of myometrium, smooth muscle fibers of uterus softens cervix and enhances uterine muslce tone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mifeprex, RU 486 stimulates uterine contractions to induce abortion give w/ prostaglandin drug for elective abortions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Induce labor and increase labor when contractions are weak put on a pump and monitor fetal HR prevent postpartum bleeding complete/incomplete abortion-miscarriage promote milk ejection |  | 
        |  | 
        
        | Term 
 
        | uterine stimulant adverse effects |  | Definition 
 
        | hypo/hyper tension, chest pain HA, dizzy, faint N,V, D vaginal pain, cramp leg cramp, joint swell, chills, fever, weak, blurred vision |  | 
        |  | 
        
        | Term 
 
        | Uterine stimulant Implications |  | Definition 
 
        | assess mother and fetal vital signs   continuous fetal monitoring if given to promote labor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | uterine relaxant stop labor before term given after 20th week before 37th also bed rest, sedation, hydration |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uterine relaxant   stimulant of Beta 2 adrenergic of uterine smooth muscle for off label use |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | used to stop labr   IV on a pump, monitor Fetal heart rate   hyperreflexive with high levels of Mag |  | 
        |  | 
        
        | Term 
 
        | Uterine relaxants adverse effects |  | Definition 
 
        | palpitations, tachycardia, HTN tremors, anxiety, insomnia, HA, dizzy N/V, anorexia, D/C Hyperglycemia, HypoKalemia* dyspnea, hyperventilation |  | 
        |  | 
        
        | Term 
 
        | Uterine relaxants Implications |  | Definition 
 
        | Asses baseline vitals of mom and baby, weight, blood glucose, renal and liver function smoking history medical and medication history give drug as ordered   |  | 
        |  |